World's Largest Resource for Cardiovascular Perfusion

+1 888-499-5672 Login

LVAD Pioneers… :(

Circuit Surfers, Perfusion.com

Editor’s Note:

This is a painting by Michael-Joshua Morris. He is a friend, a frequent contributor to this blog, as well as his own, and has been incredibly courageous in his efforts to promote awareness of VAD technology. He has had a Heartmate II for two years and counting.

He just lost a friend… that’s what this post is about .

“It goes without saying that you (Cris) and Suzanne are the MOST SPECIAL AND LOVING COUPLE I HAVE MET!!!! You guys were the first LVAD family that I was in contact with through my Blog. You have given me UNLIMITED inspiration and love to proudly strive forward.

To me Cris and Suzanne Torio set the bar for the “perfect” Husband and Wife team… There isn’t even a close second in my mind. Cris and Kids… We love you with all our strength and I am soooooooooo blessed to have known Suzanne in my lifetime, her sweet soul is a gift from God and I thank him for that. We LOVE you Suzanne… “

Frank Aprile

Leave a Reply Cancel reply

You must be logged in to post a comment.

You may also like

Main Zone, Mobile Zone, Perfusion Zone

Can Extra Protamine Eliminate Heparin Rebound Following Cardiopulmonary Bypass Surgery

Postoperative protamine infusion was able to almost totally abolish heparin rebound. In the context of this study, protamine infusion resulted in reduced postoperative bleeding but the magnitude was insufficient to alter transfusion requirements.

Blood Management, Main Zone, Mobile Zone, Multimedia Zone

Innovation of a Novel Blood Conservation Technique (EP Video)

Al Arceneaux discusses a novel blood conservation technique (18:37 minutes).

Perfusion Zone, Tiny Perfusion Letter

Association of Heparin Dose, Route, Timing, and Duration With Heparin-Induced Thrombocytopenia

Odds of HIT were increased 10-fold in adult cardiac surgery patients receiving preoperative or postoperative intravenous UFH infusion. Intraoperative UFH dose and subcutaneous route were not associated with HIT. Future study should evaluate incorporation of intravenous UFH administration, dose, and duration in HIT scoring tools for cardiac surgery patients.